| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01813253 Details | 2018-03-26 Interventional | 3 | 400 | Irinotecan Nimotuzumab Stomach Neoplas… Gastric Cancer Gastroesophagea… | - - | |||
| NCT03054948 Details | 2018-03-22 Interventional | 4 | 0 | SMOFlipid Short Bowel Syn… Home Parenteral… | Redesign of study protocol. - | |||
| NCT02269696 Details | 2018-03-22 Interventional | 3 | 0 | Metoprolol Breast Neoplasm… Mastodynia Breast Cancer | Withdrawn - | |||
| NCT01123915 2008-005142-23 Details | 2018-03-22 Interventional | 1 | 22 | Dimethyl Sulfox… HIV Infections | - - | |||
| NCT01511263 Details | 2018-03-21 Interventional | 2 | 86 | Amiodarone Anti-Arrhythmia… Diuretics Amyloidosis Immunoglobulin … Primary Amyloid… | - - | |||
| NCT00273026 Details | 2018-03-21 Interventional | 4 | - | Fluticasone Salmeterol Xina… Xhance Asthma | - - | |||
| NCT01271010 Details | 2018-03-20 Interventional | 4 | 89 | Cyclophosphamid… Fludarabine Rituximab Leukemia Leukemia, Lymph… Leukemia, Lymph… Lymphocytic Leu… | - - | |||
| NCT00623415 2006-005262-39 Details | 2018-03-20 Interventional | 2 | 30 | Flupirtine Multiple Sclero… Multiple Sclero… Sclerosis Relapsing Remit… | - - | |||
| NCT01543464 Details | 2018-03-19 Interventional | 2 | 41 | Temozolomide Melanoma Malignant Melan… | Diminished rectruitment - | |||
| NCT03235869 Details | 2018-03-15 Interventional | 1 | 0 | Durvalumab Lymphoma Lymphoma, T-Cel… Lymphoma, T-Cel… Lymphoma, T-Cel… Cutaneous T Cel… | The company pulled durvalumab from heme malignancies - | |||
| NCT03073369 Details | 2018-03-15 Interventional | 4 | 0 | Ergocalciferols Vitamin D Iron Deficienci… Kidney Diseases Renal Insuffici… Anemia CKD Chronic Kidney … Ergocalciferol Hepcidin Iron-deficiency Vitamin D | Study didn't materialize for various reasons. - | |||
| NCT02469311 Details | 2018-03-14 Interventional | 2 | 539 | Anti-Bacterial … Chlorhexidine Infections Infection Osteoarthritis | Preliminary results showed that the use of the cloths helped prevent infections. - | |||
| NCT00354107 Details | 2018-03-14 Interventional | 1/2 | 5 | Antibodies Antibodies, Mon… Brentuximab Ved… Carboplatin Cytarabine Etoposide Etoposide phosp… Hydrocortisone Hydrocortisone … Hydrocortisone … Hydrocortisone … Ifosfamide Methotrexate Lymphoma Lymphoma, Large… Lymphoma, Non-H… Recurrence Anaplastic Larg… Recurrent Child… | - Number of participants analyzed = 4. One patient was not evaluable for response. The Secondary Outcome measures will never be reported as data were not collected to assess these study aims. | |||
| NCT00169026 Details | 2018-03-14 Interventional | 4 | - | Antipsychotic A… Clozapine Alcoholism Psychotic Disor… Schizophrenia Substance-Relat… Alcohol Abuse Dual Diagnosis Psychotic Disor… Schizoaffective… Substance Abuse | - - | |||
| NCT01866943 Details | 2018-03-13 Interventional | 2 | 41 | Tranexamic Acid Hemorrhage Postoperative H… Post Operative … | - The study team is limited by a change in personnel. The data is not available classified by group: the only spreadsheet is incomplete, blinded and de-identified. The previous personnel have been contacted and are not cooperative. | |||
| NCT00705796 Details | 2018-03-13 Interventional | 1 | 0 | Methyltestoster… Testosterone Testosterone 17… Testosterone en… Testosterone un… Hypogonadism | financial constraints - | |||
| NCT02730364 Details | 2018-03-12 Interventional | 3 | 0 | Acetaminophen Oxymetazoline Pheniramine Phenylephrine Infections Respiratory Tra… Infections, Res… | The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's
decision. - | |||
| NCT02678234 Details | 2018-03-12 Interventional | 3 | 0 | Acetaminophen Oxymetazoline Phenylephrine Infections Respiratory Tra… Infections, Res… | The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's
decision. - | |||
| NCT02366663 Details | 2018-03-12 Interventional | 3 | 3 | Carmustine Cytarabine Etoposide Melphalan Rituximab Lymphoma Lymphoma, B-Cel… Lymphoma, Large… Recurrent Diffu… Refractory Diff… | Withdrawal of sponsor support - | |||
| NCT01188408 Details | 2018-03-12 Interventional | 2 | 0 | Docetaxel Prostatic Neopl… Prostate Cancer | Study shut-down in 12/2010 when NeoPharm merged with Insys. - |